Tandem Diabetes Care’s (TNDM) “Equal Weight” Rating Reiterated at Morgan Stanley

Morgan Stanley reissued their equal weight rating on shares of Tandem Diabetes Care (NASDAQ:TNDM – Free Report) in a research note released on Monday morning, Benzinga reports. The brokerage currently has a $45.00 price objective on the medical device company’s stock. A number of other research analysts have also issued reports on the company. Barclays […]

Leave a Reply

Your email address will not be published.

Previous post Archer Aviation (NYSE:ACHR) Rating Reiterated by Cantor Fitzgerald
Next post Coeur Mining (NYSE:CDE) Trading Up 7.2% After Analyst Upgrade